Anticorps Recombinant de lapin anti-CD40L/CD154
CD40L/CD154 Recombinant Antibody for FC
Hôte / Isotype
Lapin / IgG
Réactivité testée
souris
Applications
FC
Conjugaison
Non conjugué
CloneNo.
240743E6
N° de cat : 98120-1-PBS
Synonymes
Galerie de données de validation
Informations sur le produit
98120-1-PBS cible CD40L/CD154 dans les applications de FC et montre une réactivité avec des échantillons souris
| Réactivité | souris |
| Hôte / Isotype | Lapin / IgG |
| Clonalité | Recombinant |
| Type | Anticorps |
| Immunogène | Protéine recombinante |
| Nom complet | CD40 ligand |
| Masse moléculaire calculée | 29 kDa |
| Numéro d’acquisition GenBank | NM_011616.2 |
| Symbole du gène | CD154 |
| Identification du gène (NCBI) | 21947 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Protein A purfication |
| Tampon de stockage | PBS only |
| Conditions de stockage | Store at -80°C. |
Informations générales
The CD40 ligand (CD40L, TRAP, CD154), a member of the TNF superfamily of ligands, is expressed as either a 33-kd transmembrane homologue or 18-kd soluble form (sCD154). CD40L is primarily expressed on activated CD4+ T cells and on a small proportion of CD8+ T cells and platelets. It binds to CD40 on antigen-presenting cells (APC), which leads to many effects depending on the target cell type. It has been suggested that CD40/CD40L interactions regulate oxidative stress and affect various signaling pathways in both the immunological and the cardiovascular systems. The CD40/CD40L system is also involved in tumorigenesis. Its expression is tightly regulated, and abnormal levels of CD40L are associated with the pathogenesis of atheromatous plaque destabilization and thrombotic events. Multiple mutations in CD40LG gene have been identified that are associated with hyper-IgM immunodeficiency syndrome type 1.





